Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.

Authors :: Wang WD
Gale RP
Liang Y
Source :: The New England journal of medicine [N Engl J Med] 2024 May 02; Vol. 390 (17), pp. 1633-1634.
Publication Year :: 2024

Subjects :: Humans
Bone Marrow pathology
Survival Analysis
Randomized Controlled Trials as Topic
Rituximab administration & dosage
Cyclophosphamide administration & dosage
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Biomarkers analysis
Biomarkers blood
Leukemia, Lymphocytic, Chronic, B-Cell blood
Leukemia, Lymphocytic, Chronic, B-Cell diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Neoplasm, Residual blood
Neoplasm, Residual diagnosis
Neoplasm, Residual drug therapy

Full Text Access

Tools